2026 CCC | A Phase 1 Study of M3814 in Combination with MEC in Patients with Relapsed or Refractory Acute Myeloid Leukemia

2026 CCC | A Phase 1 Study of M3814 in Combination with MEC in Patients with Relapsed or Refractory Acute Myeloid Leukemia

0% Complete

Course Content

This material is non-CME, no credits are available, and a certificate will not be provided upon completion.

Course Details

Duration
0.00 hour
Released
Aug 28, 2026
Last Review
Aug 28, 2026
Expires
Aug 28, 2029

Target Audience

Physicians
Nurses
Pharmacists
Physician Associates

Accreditation

N/A